IRIS Institutional Research Information System - OPENBS Open Archive UniBS

POLI, MAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.343
EU - Europa 2.989
AS - Asia 2.523
SA - Sud America 446
OC - Oceania 57
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.222
PL - Polonia 1.016
CN - Cina 871
SG - Singapore 800
IT - Italia 484
UA - Ucraina 386
BR - Brasile 372
DE - Germania 298
HK - Hong Kong 252
FI - Finlandia 213
VN - Vietnam 193
GB - Regno Unito 154
FR - Francia 95
IN - India 94
RU - Federazione Russa 89
TR - Turchia 82
CA - Canada 72
IE - Irlanda 69
AU - Australia 54
JP - Giappone 43
BD - Bangladesh 41
AR - Argentina 33
MX - Messico 29
BE - Belgio 28
CH - Svizzera 28
ID - Indonesia 28
IQ - Iraq 26
NL - Olanda 25
SE - Svezia 25
ES - Italia 21
ZA - Sudafrica 16
CZ - Repubblica Ceca 13
EC - Ecuador 12
AT - Austria 11
VE - Venezuela 11
KR - Corea 10
PK - Pakistan 10
SA - Arabia Saudita 9
EG - Egitto 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
IR - Iran 6
NG - Nigeria 6
JM - Giamaica 5
JO - Giordania 5
KE - Kenya 5
PE - Perù 5
UZ - Uzbekistan 5
CO - Colombia 4
DO - Repubblica Dominicana 4
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
LV - Lettonia 4
MA - Marocco 4
NP - Nepal 4
PH - Filippine 4
AM - Armenia 3
CL - Cile 3
DK - Danimarca 3
LK - Sri Lanka 3
MU - Mauritius 3
MY - Malesia 3
PT - Portogallo 3
RO - Romania 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
GT - Guatemala 2
KZ - Kazakistan 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
UY - Uruguay 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KI - Kiribati 1
LB - Libano 1
LU - Lussemburgo 1
ML - Mali 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
Totale 11.404
Salva come PNG Salva come JPEG
Città #
Warsaw 1.015
Fairfield 571
Ashburn 553
Singapore 443
Woodbridge 391
Houston 285
Jacksonville 279
Hong Kong 248
Seattle 241
Chandler 220
Cambridge 219
Brescia 214
San Jose 213
Wilmington 206
Beijing 204
Ann Arbor 146
Helsinki 140
The Dalles 128
Princeton 123
Los Angeles 108
New York 104
Nanjing 102
Dearborn 85
Munich 76
Dublin 68
Lauterbourg 65
Istanbul 61
Dong Ket 50
Melbourne 50
Council Bluffs 48
Ho Chi Minh City 41
Shenyang 41
Dallas 40
São Paulo 38
Hanoi 36
San Francisco 36
Des Moines 34
San Diego 33
Santa Clara 33
Turku 33
Nanchang 31
Shanghai 31
Chicago 30
Moscow 30
Orem 29
Milan 28
Redondo Beach 28
Brussels 26
Jiaxing 25
Verona 25
Buffalo 24
Changsha 22
Hebei 22
Jakarta 22
Croydon 21
Washington 20
Tianjin 19
Jinan 18
Montreal 18
Tokyo 18
Toronto 17
Chennai 16
Hangzhou 16
Phoenix 16
Denver 15
Frankfurt am Main 15
Ottawa 15
Boston 14
Zhengzhou 14
London 13
Stockholm 13
Guangzhou 12
Nuremberg 12
Brooklyn 11
Manchester 11
Ankara 10
Curitiba 10
Amsterdam 9
Boardman 9
Charlotte 9
Da Nang 9
Johannesburg 9
Lappeenranta 9
Ningbo 9
Rio de Janeiro 9
Baghdad 8
Dhaka 8
Haiphong 8
Kunming 8
Kyoto 8
Mexico City 8
Rome 8
Augusta 7
Elk Grove Village 7
Granada 7
Poplar 7
Turin 7
Vienna 7
Abuja 6
Atlanta 6
Totale 7.920
Salva come PNG Salva come JPEG
Nome #
Mitochondrial ferritin deficiency reduces male fertility in mice 349
Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity 342
Inhibition of glutathione peroxidase 4 primes mouse C2C12 myoblasts and rhabdomyosarcoma cell lines to ferroptosis 336
Heparanase overexpression reduces hepcidin expression, affects iron homeostasis and alters the response to inflammation 329
Hepcidin antagonists for potential treatments of disorders with hepcidin excess 325
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma. 285
The importance of eukaryotic ferritins in iron handling and cytoprotection 254
Ferritin exhibits Michaelis-Menten behavior with oxygen but not with iron during iron oxidation and core mineralization 252
Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells 244
Energetics of surface confined ferritin during iron loading 210
DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease. 209
GLICOSAMINOGLICANI SOLFORATI, INCLUDENTI L'EPARINA, L'EPARINA A BASSO PESO MOLECOLARE E I LORO DERIVATI, PERL'IMPIEGO NEL TRATTAMENTO TERAPEUTICO DI ANEMIE E PER L'INIBIZIONE DELL'ESPRESSIONE DI EPCIDINA 204
High sulfation and a high molecular weight are important for anti-hepcidin activity of heparin 202
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 197
Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders. 195
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo 193
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo 192
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines 192
Erastin is a strong inducer of ferroptosis in human rhabdomyosarcoma cell lines 177
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 176
Ferritin, cellular iron storage and regulation 172
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. 172
Iron release from ferritin by flavin nucleotides. 169
Study of ferritin self-assembly and heteropolymer formation by the use of Fluorescence Resonance Energy Transfer (FRET) technology 166
Non-anticoagulant heparins are hepcidin antagonists for the treatment of anemia 166
Association analysis between anterior-pharynx defective-1 genes polymorphisms and Alzheimer's disease. 165
Production and characterization of functional recombinant hybrid heteropolymers of camel hepcidin and human ferritin H and L chains 165
Expression and characterization of the ferritin binding domain of Nuclear Receptor Coactivator-4 (NCOA4) 163
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 160
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation 159
Facilitated diffusion of iron(II) and dioxygen substrates into human H-chain ferritin. A fluorescence and absorbance study employing the ferroxidase center substitution Y34W. 157
Analysis of the hepcidin mutant R59G, which causes an adult-onset type of hemochromatosis 157
Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice 156
Apolipoprotein E haplotyping by denaturing high performance liquid chromatography. 153
Iron Oxidation and Core Formation in Recombinant Heteropolymeric Human Ferritins 152
BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues 152
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 150
The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. 149
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. 149
RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. 145
The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation 141
NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells 140
HEPARIN BINDING DOMAINS IN BMP6: STUDY ON THE SYNTHETIC PEPTIDES AND THE RECOMBINANT PROTEIN 138
Antiangiogenic activity of aplidine, a new agent of marine origin 136
Immunoassay for human serum hemojuvelin 133
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 133
Mutant ferritin L-chains that cause neurodegeneration act in a dominant negative manner to reduce ferritin iron incorporation 131
Cellular binding analysis of recombinant hybrid heteropolymer of camel hepcidin and human ferritin H chain. The unexpected human H-ferritin binding to J774 murine macrophage cells 131
Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development 130
Ferritin is secreted via 2 distinct nonclassical vesicular pathways. 127
Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells 126
Interaction between the APOE varepsilon4 allele and the APH-1b c+651T>G SNP in Alzheimer's disease. 124
Ferritin-Ferroxidase Activity: A Potent Inhibitor of Osteogenesis 123
The sedimentation properties of ferritins. New insights and analysis of methods of nanoparticle preparation. 121
Heat-induced proteasomic degradation of HSF1 in serum-starved human fibroblasts aging in vitro 119
Mitochondrial ferritin attenuates doxorubicin effects on iron homeostasis. 118
Silencing of ABCB7 in HeLa cells causes an iron deficient phenotype and mitochondrial iron overload. 116
Metabolic adaptation to tissue iron overload confers tolerance to malaria 114
Silemcing of ABCB7 in HeLa cells causes an iron deficient phenotype and mitochondrial iron overload. 112
Hemojuvelin: A new link between obesity and iron homeostasis 111
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 107
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 107
Silencing of pantothenate Kinase-2 (Pank2) in HeLa cells causes alterations of iron homeostasis that are partially reverted by the expression of mitochondrial ferritin. 106
Biochemical, Biophysical and Functional Characterization of an Insoluble Iron Containing Hepcidin-Ferritin Chimeric Monomer Assembled Together with Human Ferritin H/L Chains at Different Molar Ratios 102
Vascular-targeting activity of ZD6126, a novel tubulin-binding agent 100
Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative 90
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 86
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription 80
Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers 69
Pentosan polysulfate to control hepcidin expression in vitro and in vivo 64
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo 61
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 54
Intraocular iron injection induces oxidative stress followed by elements of geographic atrophy and sympathetic ophthalmia 47
Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells 6
Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization 5
Totale 11.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 0 0 0 0 0 0 89
2021/2022569 26 106 14 13 12 28 49 35 35 70 61 120
2022/2023632 80 36 30 34 50 139 6 65 94 9 40 49
2023/2024597 39 17 91 29 46 100 13 35 113 26 20 68
2024/20251.466 18 16 13 191 134 145 145 60 133 123 272 216
2025/20263.183 297 373 224 479 392 262 435 118 215 246 110 32
Totale 11.648